부산대학교 도서관

Simple Summary: Surgery of locally advanced rectal cancer involving the anal sphinkter or recurrent anal cancer demands reliable surgical margins resulting in local defects. Skin-soft tissue reconstruction after extended or extralevator approaches to abdominoperineal resection for lower gastrointestinal tract cancers or inflammatory tumors has been described mainly with muscle flaps such as the vertical rectus abdominis muscle flap. In this article, we demonstrate our tailored approach with the use of bilateral adipo-fasciocutaneous perforator flaps of the inferior gluteal artery in a VY manner after surgery in 29 cases. The relatively simple surgical technique and postoperative course are presented. Surgery was performed with a minimally invasive abdominal approach combined with open perineal extralevator abdominoperineal resection and immediate flap reconstruction by a plastic surgeon. The rate of early perineal complication after plastic reconstruction was 19.0%, requiring local revision due to local infection. The use of bilateral adipo-fasciocutaneous perforator flaps of the inferior gluteal artery is a reliable, rapid, and safe option for pelvic floor reconstruction with minimal donor site morbidity. Background: Extralevator abdominoperineal excision (ELAPE) is a relatively new surgical technique for low rectal cancers, enabling a more radical approach than conventional abdominoperineal excision (APE) with a potentially better oncological outcome. To date, no standard exists for reconstruction after extended or extralevator approaches of abdominoperineal (ELAPE) resection for lower gastrointestinal cancer or inflammatory tumors. In the recent literature, techniques with myocutaneous flaps, such as the VY gluteal flap, the pedicled gracilis flap, or the pedicled rectus abdominis flaps (VRAM) are primarily described. We propose a tailored concept with the use of bilateral adipo-fasciocutaneous inferior gluteal artery perforator (IGAP) advancement flaps in VY fashion after ELAPE surgery procedures. This retrospective cohort study analyzes the feasibility of this concept and is, to our knowledge, one of the largest published series of IGAP flaps in the context of primary closure after ELAPE procedures. Methods: In a retrospective cohort analysis, we evaluated all the consecutive patients with rectal resections from Jan 2017 to Sep 2021. All the patients with abdominoperineal resection were included in the study evaluation. The primary endpoint of the study was the proportion of plastic reconstruction and inpatient discharge. Results: Out of a total of 560 patients with rectal resections, 101 consecutive patients with ELAPE met the inclusion criteria and were included in the study evaluation. The primary direct defect closure was performed in 72 patients (71.3%). In 29 patients (28.7%), the defect was closed with primary unilateral or bilateral IGAP flaps in VY fashion. The patients' mean age was 59.4 years with a range of 25–85 years. In 84 patients, the indication of the operation was lower rectal cancer or anal cancer recurrence, and non-oncological resections were performed in 17 patients. Surgery was performed in a minimally invasive abdominal approach in combination with open perineal extralevatoric abdominoperineal resection (ELAPE) and immediate IGAP flap reconstruction. The rate of perineal early complications after plastic reconstruction was 19.0%, which needed local revision due to local infection. All these interventions were conducted under general anesthesia (Clavien–Dindo IIIb). The mean length of the hospital stay was 14.4 days after ELAPE, ranging from 3 to 53 days. Conclusions: Since radical resection with a broad margin is the standard choice in primary, sphincter-infiltrating rectal cancer and recurrent anal cancer surgery in combination with ELAPE, the choice technique for pelvic floor reconstruction is under debate and there is no consensus. Using IGAP flaps is a reliable, technical, easy, and safe option, especially in wider defects on the pelvic floor with minimal donor site morbidity and an acceptable complication (no flap necrosis) rate. The data for hernia incidence in the long term are not known. [ABSTRACT FROM AUTHOR]